CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Operating activities
Net income (loss)	$ 5,357	$ (159)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization including financing costs	116	299
Change in fair value of derivative financial instruments	(99)	41
Non-cash equity grants	472	206
Deferred expense (benefit)	(4,597)	0
Changes in operating assets and liabilities
Accounts receivable	(429)	1,085
Prepaid workers' compensation and other current assets	89	51
Other assets	1,030	(303)
Accounts payable, accrued payroll, accrued expenses and other current liabilities	(269)	628
Other long term liabilities	(5)	(43)
Net cash provided by operating activities	1,665	1,805
Investing activities
Purchase of equipment and improvements	(13)	(9)
Net cash used in investing activities	(13)	(9)
Financing activities
Net repayments on bank loan payable	(951)	(1,412)
Rights offering expenses	0	(14)
Repayments of capital lease obligations	(22)	(51)
Net repayment on convertible debentures	(140)	0
Proceeds from exercise of warrants	52	0
Repurchased shares of common stock held as treasury stock	21	0
Repurchased shares of common stock subsequently canceled	(112)	0
Net cash used in financing activities	(1,152)	(1,477)
Net increase in cash and cash equivalents	500	319
Cash and cash equivalents at beginning of period	3,408	3,089
Cash and cash equivalents at end of period	3,908	3,408
Supplemental disclosures of cash flow information
Cash paid during the period for interest	124	94
Cash paid during the period for income taxes	0	0
Non-cash settlement of warrants	$ 62	$ 0